In contrast, mutants of cFos—which enhances stability, DNA binding activity [41], and transactivation activity [40] of AP-1 heterodimers—may be more powerful drivers of dysregulated AP-1 activity in RA. Here, JUNB is linked to rheumatoid arthritis.